The study, published in the journal Menopause on Wednesday, also suggests that women with a history of hypertension during pregnancy who use hormone therapy are more likely to report more bothersome symptoms than women with no such history. Continue reading →

Like most expectant mothers, Stephanie King had a firm idea of how she wanted the birth of her children to go. But when the time came to have her twins in July 2019, her plans started unravelling Continue reading →

Hey yall! Its been a while since my last article here. Continue reading →

The Bio-identical Hormone Replacement Therapy Market research report added by Market Study Report provides a succinct analysis on the recent market trends. In addition, the report offers a thorough abstract on the statistics, market estimates and revenue forecasts, which further highlights its position in the industry, in tandem with the growth strategies adopted by leading industry players. The Bio-identical Hormone Replacement Therapy market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. Continue reading →

Pandemic Impact Analysis 2020: According to latest report, titled Contract Pharmaceutical Packaging Market: Industry Trends, Share, Size, Grsowth, Opportunity and Forecast 2020-2027 The market is supposed to witness growth during the forecast period due to growing demand at the end user level. Geographical areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa are also considered for the market analysis. Continue reading →

Personalized medical services, called concierge services, have become big business during the pandemic. The comfort and luxury of having the doctor come to your door instead of braving traffic and potentially germ-filled waiting rooms has garnered a well-heeled following. While basic telemedicine can be restricted by insurance regulations and complicated healthcare portals, concierge care is not dependent upon insurance and offers personalized care, often in the comfort of the patient's own home Continue reading →

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the pivotal Phase 3 KEYNOTE-590 trial evaluating KEYTRUDA, Mercks anti-PD-1 therapy, in combination with chemotherapy (cisplatin plus 5-fluorouracil [5-FU]), met its primary endpoints of overall survival (OS) and progression-free survival (PFS) for the first-line treatment of patients with locally advanced or metastatic esophageal cancer. Based on an interim analysis conducted by an independent Data Monitoring Committee, KEYTRUDA in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in OS and PFS compared with chemotherapy (cisplatin plus 5-FU), the current standard of care, in the intention-to-treat (ITT) population Continue reading →